Endpoints named Kronos Bio as one of 11 most promising startups in biotech. Built on high-throughput screening techniques developed by MIT Center for Precision Cancer Medicine member Angela Koehler, the company takes aim at “undruggable” cancer targets. Skyhawk, which draws on the research and expertise of several KI members, also made the list.